All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

HER2-Positive Patients Benefit From Combination Therapy of Trastuzumab and Lapatinib

January 17th 2012

Two new studies suggest that dual inhibition of HER2 might serve as a better approach to treating patients with HER2-positive breast cancer.

Updated IV Catheter Infection Prevention Guidelines

January 17th 2012

Every clinician should have this resource at their fingertips.

FDA Issues New Safety Warnings on Brentuximab, Including Risk of Rare Brain Infection

January 13th 2012

The FDA and Seattle Genetics announced that new warning labels would be issued for brentuximab vedotin.

DNA Analysis Finds First Gene Implicated in Prostate Cancer

January 12th 2012

A statistical analysis led to the discovery of the first high-risk genetic mutation associated with hereditary prostate cancer.

Robotic-Assisted Surgery for Prostate Cancer

January 9th 2012

The public may believe it's superior to surgery performed solely by humans, but are they correct?

Tivozanib Demonstrates Better PFS Than Sorafenib, but Failed to Meet Investors Expectations

January 3rd 2012

The investigational drug, tivozanib, showed improved rates of PFS in patients with advanced RCC than the already-approved sorafenib.

Nursing Test Banks

January 3rd 2012

The Internet has made it easy for students to obtain test questions.

Progress in Treating Advanced Breast Cancer

December 13th 2011

Promising study results were released at the San Antonio Breast Cancer Symposium.

ODAC Unanimously Supports Axitinib for Renal Cell Carcinoma

December 8th 2011

ODAC unanimously voted to recommend the approval of axitinib for the second-line treatment of patients with advanced renal cell carcinoma.

What is Thoracic Surgery?

December 8th 2011

"What is Thoracic Surgery?" is a good question.

Stem Cell Donors Now Can Be Paid

December 5th 2011

A federal appeals court decides that stem cells are a renewable tissue.

Adverse Drug Events

November 29th 2011

Four commonly prescribed drugs are responsible for most emergency room visits.

FDA Says Avastin Not Safe or Effective for Patients With Breast Cancer

November 18th 2011

The FDA commissioner announced the withdrawal of its approval for bevacizumab (Avastin) to treat patients with breast cancer.

FDA Grants Orphan Drug Status to Erwinaze for Treatment of Acute Lymphoblastic Leukemia

November 18th 2011

The FDA granted orphan drug approval to Erwinaze (asparaginase Erwinia chrysanthemi) to treat acute lymphoblastic leukemia (ALL).

Ruxolitinib Gains FDA Approval for Bone Marrow Disease

November 17th 2011

The FDA approved ruxolitinib (Jakafi) as the first drug to specifically treat patients with myelofibrosis, a bone marrow disease.

World Diabetes Day 2011

November 15th 2011

On November 14th, World Diabetes Day, a look at the recent diabetes statistics are concerning.

Who Most Influences Lifestyle Choices?

November 8th 2011

Global study identifies who people turn to for health advice.

Cetuximab Approved by FDA for Patients With Late-Stage Head and Neck Cancer

November 7th 2011

Cetuximab (Erbitux) was approved by the FDA for treating patients with late-stage head and neck cancer in combination with chemotherapy.

Updated Lung Cancer Screening Guidelines Released

November 1st 2011

The National Comprehensive Cancer Network releases newest update.

Metastatic Colorectal Cancer Study Demonstrates Improved Overall Survival

October 26th 2011

A late phase metastatic colorectal cancer trial was stopped after demonstrating a statistically significant improvement in OS.